Company / Current Liabilities per Share
Olema Pharmaceuticals, Inc. Current Liabilities per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.71
FY2024
5-year range
$0.23 / $0.71
FY2020-FY2024
Trend
+48.8%
vs FY2023
Sector context
#131 of 210
Health Care
What the data says
At $0.71, Olema Pharmaceuticals, Inc.'s current liabilities per share ranks #80 of 210 in the Health Care sector. Current Liabilities per Share has increased for 3 consecutive years, from $0.23 in FY2021 to $0.71 in FY2024.
Based on SEC 10-K filings.
0.71 in FY2024 with a 3-year CAGR of +46.0%.
Increased from $0.41 to $0.71 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +46.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#80 of 210 in Health CareTop 38% of 210This company $0.71 Sector average $23.79
▼
-97.0% below sector average
Key checks
Key Insights
- Olema Pharmaceuticals, Inc.'s current liabilities per share has grown for 3 consecutive years.
- In FY2024, current liabilities per share increased 48.8% year-over-year.
- Ranks #131 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.71 | +48.8% |
| FY2023 | $0.48 | +15.5% |
| FY2022 | $0.41 | +81.3% |
| FY2021 | $0.23 | -65.1% |
| FY2020 | $0.65 | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026